Research and Development

Showing 15 posts of 9599 posts found.

pharmafocus_march_2020_cover

The March 2020 issue of Pharmafocus is available to read free online now!

February 27, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing England, Pharmafocus, UK, mumps, pharma, pharmacovigilance, type 2 diabetes

The latest monthly edition of Pharmafocus, the March issue, is available to read for free online now! The coronavirus continues …

Female participation up in 2019 US clinical trials, but minority representation down

February 27, 2020 Medical Communications, Research and Development FDA, clinical trials, pharma

The FDA’s Drugs Trials Snapshots 2019 report has been released, clarifying the demographic distribution of participants who were included in …
shutterstock_95714119

US Judge rules that a decade of unpublished trial results must be made public

February 27, 2020 Medical Communications, Research and Development FDA, US, clinical trials, pharma

A federal judge in New York’s Southern District has ruled that 10 years of unpublished clinical trial data must now …
shutterstock

First US coronavirus trial launched into Gilead’s remdesivir

February 26, 2020 Research and Development FDA, Gilead, US, coronavirus, pharma

The first US clinical trial investigating a treatment for the COVID-19 coronavirus has been launched by the US National Institute …
hqdefault

Takeda acquires PvP Biologics after successful Phase 1 study of Celiac Disease treatment

February 26, 2020 Research and Development Celiac, PvP, Takeda, phase 1, phase III

Takeda has acquired PvP Biologics following the conclusion of a Phase 1 study of the investigational medicine TAK-062 for the …

Global cases of coronavirus rise, as first US soldier in South Korea tests positive for the virus

February 26, 2020 Research and Development

The number of global cases of COVID-19 continues to rise as several nations work to contain outbreaks, in particular South …
nice_new_london_office_internal_3_web

NICE rejects Roche’s Polivy combo in relapsed or refractory diffuse large B-cell lymphoma

February 26, 2020 Manufacturing and Production, Research and Development, Sales and Marketing NHS, NICE, Polivy, Roche

It has been revealed that UK drug watchdog NICE has chosen to reject Roche’s Polivy (polatuzumab vedotin), used alongside rituximab …
36745826313_86e4ffa6ac_b

New Johnson & Johnson study aiming to add stroke detection to Apple Watch

February 26, 2020 Research and Development Apple, Janssen, Johnson & Johnson, apple watch, iphone, stroke

Johnson & Johnson announced that Janssen Pharmaceuticals will work in collaboration with Apple to explore apps for stroke detection. It …
160x100

2020 Veeva Unified Clinical Operations Survey

February 24, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing pharma, survey, veeva

Every year, Veeva asks clinical professionals to take part in the Veeva Unified Clinical Operations Survey to help the industry …
francesa

Teva’s Austedo fails in two paediatric Tourette’s syndrome trials

February 21, 2020 Medical Communications, Research and Development Austedo, Teva, pharma, tourette's

Israeli firm Teva has shared disappointing results for its vesicular monoamine transporter 2 (VMAT2) Austedo (deutetrabenazine) after it failed to …
top_10_image_2

Top Ten most popular articles on Pharmafile.com this week

February 21, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Drug market, Europe, coronavirus, opioid crisis, opioids

The coronavirus is again in the news, with the Indian government considering banning exports of medicine as the epidemic threatens …
shutterstock_57369385

FDA approved over 1,000 generic drugs in 2019

February 20, 2020 Research and Development, Sales and Marketing FDA, generic drugs, pharma

The FDA covered a lot of ground in 2019 when it came to generic drugs, awarding at least tentative approval …
pfizer-building-logo1web

Europe approves first treatment for transthyretin amyloidosis in cardiomyopathy patients: Pfizer’s Vyndaqel

February 19, 2020 Research and Development, Sales and Marketing Europe, Pfizer, Vyndaqel, pharma, transthyretin amyloidosis

The European Commission (EC) has awarded marketing approval to Pfizer’s Vyndaqel (tafamidis), it has emerged, for the treatment of wild-type …
5997920696_ecb224068e_b

CEO of PixarBio Corporation sentenced to prison for defrauding investors

February 19, 2020 Research and Development Biopharmaceuticals, CEO, FDA, corruption, fraud, investors

Frank Reynolds, the CEO of Boston based PixarBio Corporation, was sentenced to seven years in prison for defrauding investors and …
5204602349_c87b204860_b_1

FDA teams up with Indian government to crack down on illicit drugs shipments

February 19, 2020 Research and Development FDA, FDA India, FDA trade, Indian Pharma

The FDA announced yesterday its first successful bilateral enforcement operation with the Government of India, where they stopped 500 shipments …
The Gateway to Local Adoption Series

Latest content